Zealand Pharma
Clinical trials sponsored by Zealand Pharma, explained in plain language.
-
New drug could cut IV feeding days for short bowel patients
Disease control Recruiting nowThis study tests a drug called glepaglutide in adults with short bowel syndrome who need IV nutrition at least 3 days a week. The goal is to see if the drug can safely reduce the amount of IV nutrition needed. About 90 participants will receive either the drug or a placebo twice …
Phase: PHASE3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Healthy volunteers needed to test safety of experimental drug ZP9830
Knowledge-focused Recruiting nowThis early-stage study is testing a new drug, ZP9830, in 124 healthy volunteers aged 18 to 45. The main goal is to see if the drug is safe and how the body processes it. No treatment benefit is expected, as the study is designed to gather safety information before testing in pati…
Phase: PHASE1 • Sponsor: Zealand Pharma • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC